Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products

Published:2013-08-05 Issue:1 Volume:13 Page:25-40
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Gamalo Meg A.¹,Tiwari Ram C.¹,LaVange Lisa M.¹

Affiliation:

1. Office of Biostatistics; Food and Drug Administration; Silver Spring MD, 20993-0002 USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pst.1588/fullpdf

Reference54 articles.

1. Declaration of Helsinki. Ethical principles for medical research involving human subjects;World Medical Association;Journal of the American Medical Association,2000

2. Placebo controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues;Temple;Annals of Internal Medicine,2000

3. The continued unethical use of placebo controls;Rothan;New England Journal of Medicine,1994

4. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics;D'Agostino;Statistics in Medicine,2003

5. Some fundamental issues with non-inferiority testing in active controlled clinical trials;Hung;Statistical in Medicine,2003

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dynamic power prior approach to non‐inferiority trials for normal means;Pharmaceutical Statistics;2023-11-14

2. Practical approaches to Bayesian sample size determination in non‐inferiority trials with binary outcomes;Statistics in Medicine;2023-01-20

3. Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER;Therapeutic Innovation & Regulatory Science;2022-12-02

4. Borrowing historical information for non-inferiority trials on Covid-19 vaccines;The International Journal of Biostatistics;2022-04-27

5. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials;Journal of Biopharmaceutical Statistics;2022-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3